Non-Dairy Yogurt Market Is Valued At Nearly US$ 6.77 Bn In 2021 And Is Projected To Grow At A CAGR Of 5.8% Through 2032 With A Projection Value US$ 12.2 Bn By 2032

Stimulated by innovations in flavored yogurt varieties, global non-dairy yogurt market is set for an upward growth trend over the course of next decade. Expected to reach the US$ 12.2 Bn mark by 2032 end, non-dairy yogurt market will be primarily driven by rise in inclination towards the consumption of plant-based products. The trend of natural and organic is also significantly contributing to the growth of non-dairy yogurt market.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-4120

In contrast to its conventional counterpart, organic non-dairy yogurt would account for a third of global market value in 2022. This share is however expected to expand in the near future, attaining the market value of over US$ 3 Bn at the end of projection period. The demand for flavored non-dairy yogurt continues to rise owing to widespread availability and innovations in terms of taste.

Production of Non-dairy yogurt should start with Cultured milk, which can be made from nearly any non-dairy source, including legume, nut, seed, grain, or coconut milk. We need to choose a thickener that matches our nutritional needs in order to make a thick yogurt. Before heating the milk and beginning the culture process, certain thickening agents must be applied.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-4120

Key Takeaways – Non-Dairy Yogurt Market Study

  • The demand for coconut yogurt will increase at a CAGR of ~5.8% during the forecast period (2022-2032).
  • Demand for global soy non-dairy yogurt in global market roughly equates the value of US $ 2 Bn and will account for 2/5th share in total market revenue in the near future.
  • Sales of non-dairy yogurt is foreseen to be higher in countries of South Asia and East Asia.
  • Organic non-dairy yogurt is yet to enter the mainstream.
  • Increasing demand for natural and organic plant-based food products among consumers resulted in the increased usage of non-dairy yogurt in the food and beverages industry.
  • The population allergic to nuts and seeds may remain a longstanding penetration challenge facing non-dairy yogurt market players.
  • Consumers’ choices nowadays reflect healthy and cost-effective preferences along with social and moral values, where non-dairy yogurt offers ethical and environmentally-friendly products to these consumers.

Increasing incidences of lactose intolerance are translating into substantial demand for lactose-free, plant-based dairy products. These products that are witnessing high demand include soy yogurt, almond yogurt, coconut yogurt, oat yogurt, and rice yogurt.

For any queries linked with the report, ask an analyst
https://www.futuremarketinsights.com/ask-question/rep-gb-4120

What Does Competitive Landscape Analysis Reveal?

Key manufacturers are focusing to increase expenditure for research and development activities to introduce innovative non-dairy yogurt flavors. These manufacturers are also strategizing for portfolio expansion and supply chain management to improve their foothold around the world. Plant-based dairy products as a concept are practically unfamiliar in rural areas and certain cities in developing countries, are signifying comparatively low growth prospects of the non-dairy yogurt market in many countries. This scenario is anticipated to change in the next coming years on the account of macro factors which includes Internet penetration, which has been prompting the unification of media and food culture.

Female Pelvic Implants Market to exhibit growth at a CAGR of 2.8% between 2022 and 2031

The female pelvic implants market will reach a valuation of US$ 245 Mn in 2021, according to the latest Future Market Insights (FMI) analysis. The overall sales outlook remains positive with female pelvic implant demand forecast to total US$ 322.6 Mn by 2031, as the market continues to exhibit growth at a CAGR of 2.8% between 2021 and 2031.

As per FMI, the top five players comprising Johnson & Johnson, Coloplast A/S, Becton, Dickinson and Company, Boston Scientific Corporation, and Cook Medical constitutes around 75% of the overall market.

increasing incidence of vaginal disorders among aged women coupled with the non-availability of other treatment options for SUI and POP will continue increasing the demand in the female pelvic implants market. According to the U.S. FDA, the number of women who have POP is estimated to surge by 46%, to 4.9 million, by 2050.

To remain ahead of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-3422

According to the American Urological Association (AUA/SUFU), the incidence of stress urinary incontinence (SUI) in women was reported to be as high as 49%. The incidence of stress urinary incontinence is high in women with poor or weakened pelvic supports. This disease affects the lives of women to a great extent and is widespread in the older population.

However, the low rate of efficacy after pelvic implantation and the problems of pelvic organ prolapse are hampering the growth of the female pelvic implants market.  COVID-19 is anticipated to have a moderately negative impact on the female pelvic implants market due to implementation of lockdown. Supplies and demand were jolted by the massive spread of the infection, which staggered the growth of the female pelvic implants market.

Key Takeaways from Female Pelvic Implants Market Study

  • Vaginal sling/tapes demand is anticipated to gain maximum revenue share of more than 68%, rising at an expected CAGR of 2.5% owing to the high demand to treat stress urinary incontinence.
  • Hospitals followed by ambulatory surgical centers are leading users of female pelvic implants growing owing to the rising number of POP and SUI patients.
  • The U.S. accounts for more than 83% of the North America market, driven by the high incidence of pelvic organ prolapse.
  • The U.K.is a leading market in Europe. It is expected to account for nearly 13% of demand registered in Europe by 2031. Implementation of government funded awareness programs will remain a chief growth driver.
  • Over 30% of the South Asia market is held by India. Growth in the country is propelled by significant investments in the expansion of healthcare sector.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-3422

Key Companies Profiled :

  • Johnson & Johnson Services, Inc.
  • Coloplast A/S
  • Dipromed Srl
  • Boston Scientific Corporation
  • pfm medical ag
  • Betatech Medical
  • Promedon Group
  • Caldera Medical
  • Cook Medical

Key Segments Covered:

  • Product Type,
  • Indication,
  • End-User, and Region

For in-depth insights, Download a PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-3422

Key Regions Covered

  • North America,
  • Latin America,
  • Europe,
  • East Asia,
  • South Asia,
  • Oceania Middle East & Africa

Contact Us:                                                      

Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Vulvodynia Treatment Market 2022 by Global Key Players, Types, Applications, Countries, Industry Size and Forecast to 2028

Future Market Insights (FMI) has published a new research report on vulvodynia treatment market. The report has been titled, “Vulvodynia Treatment Market: Global Industry Analysis 2013 – 2017 and Opportunity Assessment 2018 – 2028.”  The report states that a recent Harvard study showed that there are approximately 6 million American women who are suffering from vulvodynia. Over 60% of patients’ report of visiting three or more health care providers for diagnosis and an astonishing 40% of patients remain undiagnosed. This study also reported that 40% of women with painful symptoms did not even seek medical care. Associations such as the National Vulvodynia Association (NVA) are playing a vital role in spreading awareness regarding Vulvodynia treatment. The NVA announced the launch of “Indivisible: Breaking the Silence”, a campaign empowering women with vulvodynia to break their silence and improve the path to diagnosis and treatment.

Request a sample to obtain authentic analysis and comprehensive market insights at- https://www.futuremarketinsights.com/reports/sample/rep-gb-4985

In order to cater to the need of the growing number of patients, companies are looking out for treatments and drugs that can subside the pain related to vulvodynia. Towards this, they are investing in research and development and mergers and acquisitions. For instance, in January 2016, Merck & Co. Inc., acquired IOmet Pharma Ltd., a privately held U.K.-based drug discovery company focused on the development of innovative medicines for the treatment of cancer. The other leading companies operating in the market are Eli Lilly and Company, AstraZeneca Plc., GlaxoSmithKline Plc., Pfizer Inc., Johnson & Johnson Services, Inc., and Allergan plc, among others.

According to the report, the global vulvodynia treatment market is expected to register a CAGR of 6.1% over the forecast period of 2018 and 2028. The market was worth US$ 4,261.2 Mn in 2017 and is expected to rise to a valuation of US$ 8,091.6 Mn by the end of 2028.

Discover more about report analysis with figures and data tables, along with the table of contents. Ask an Analyst- https://www.futuremarketinsights.com/ask-question/rep-gb-4985

Growing Adoption to Augur Well for Global Market Revenue Growth

The swelling number of patients suffering from vulvodynia and harsh nature of chronic vulvar pain have led to the adoption of early diagnosis and treatment. The adequate results of medical treatments such as drugs, injections and creams have increased the preference for medication to treat vulvodynia. Furthermore, increasing adoption of medicinal treatments of vulvodynia has resulted in an increase in the sales of hormones, local anesthetics, and antidepressants. Additionally, promising compensation policies in most of the developed countries are also expected to act as a value driver to the growth of the global vulvodynia treatment market. On the other hand, the growing prevalence of the vulvodynia disease among women across the globe is a core factor that is pushing the growth of the vulvodynia treatment market. Vulvodynia is a very common disease in the United States and across the globe. Nevertheless, the ailment remains underdiagnosed or in some cases also incompetently treated.

Lethargic Research and Development for Vulvodynia Treatment Drugs to Slow Down Market Growth

Owing to the absenteeism of detailed information by patients, ignorance of the cause of vulvar pain, and satisfactory results of anticonvulsants and tricyclic antidepressants, researchers are unable to unveil the exact cause of vulvodynia and thereby the R&D on vulvodynia drugs is limited. After anticonvulsants and tricyclic antidepressants, only serotonin and norepinephrine reuptake inhibitors (SNRIs) drugs have showed positive results. Furthermore, if observed, the research and development for vulvodynia treatment is also in a very sluggish phase.

Contact Sales for Further Assistance in Purchasing this Report- https://www.futuremarketinsights.com/checkout/4985

Contact Us:                                                      

Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Enzyme Replacement Therapy Market is predicted to expand at a CAGR of 6.7% to attain a net worth of US$ 13.8 Bn by the end of 2028

According to the latest research published by Future Market Insights, the global enzyme replacement therapy market is poised to expand at 6.5% CAGR over the forecast period 2022–2028. The global market for enzyme replacement therapy is expected to exceed US$ 13,776.2 Mn by 2028 end, attesting the highest growth rate by Japan, which is expected to expand at 12.5% CAGR over 2022–2028.

Increasing per capita healthcare expenditure in North America is expected to push market revenue growth. The rapidly developing healthcare infrastructure and increasing awareness programmes in the highly populous regions of Asia Pacific and China is expected to play an important role in driving revenue growth of the global enzyme replacement therapy market.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-3167

Global Enzyme Replacement Therapy Market: Segmentation & Forecast

The global enzyme replacement therapy market has been segmented on the basis of therapeutic condition, route of administration, distribution channel and region. Therapeutic conditions in the enzyme replacement therapy market include fabry disease, gaucher disease, mucopolysaccharidosis, pompe disease, lysosomal acid lipase deficiency and others.

Globally, the mucopolysaccharidosis therapeutic condition is the most attractive segment. Injectable segment remains the most lucrative route of administration in the enzyme replacement therapy market. Among all distribution channels for enzyme replacement therapy, speciality treatment pharmacies are expected to be the most lucrative, followed by hospital pharmacies.

Global Enzyme Replacement Therapy Market: Regional Insights

With nearly 25%-30% market share, North America dominated the global enzyme replacement therapy market in 2017, partly due to the presence of leading market players in the region. In developing regions such as Latin America, advancements in medical facilities are helping the region cope with healthcare crisis. Medical facilities in Brazil are equivalent with hospitals in the United States, with some even exceeding American standards. Brazil offers everything from large, full service hospitals to smaller, intimate private clinics.

Brazil has developed into a centre of excellence for healthcare in Latin America, with major universities that support research, teaching and training of medical professionals. Western Europe is the second largest market globally and is expected to be valued at US$ 2,893.2 Mn by 2028, with France, Italy and Spain projected to witness significant growth rates. Japan is expected to be the third largest market for enzyme replacement therapy.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-3167

Key Research Findings

  • Enzyme replacement therapy is used in the treatment of rare diseases and the global market is projected to create incremental opportunity of US$ 6,448.3 Mn between 2022 and 2028
  • When compared to other established markets such as North America, the enzyme replacement therapy markets in Japan and Western Europe are expected to witness fast and steady growth, partly due to the increasing governmental support and growing demand for enzyme replacement therapy for the treatment of rare diseases.

Global Enzyme Replacement Therapy Market: Competitive Landscape

The global market is highly consolidated owing to the presence of several players. Some of the key players are Sanofi (Genzyme Corporation), Shire, Pfizer, Inc., Alexion Pharmaceuticals, Inc., BioMarin Pharmaceutical, Inc., Ultragenyx Pharmaceutical, Inc., Johnson & Johnson Services, Inc., Allergan, Leadiant Biosciences, Inc., and others.

Companies in the global ERT market are focussing on strategic initiatives such as alliances and agreements, collaborations, increasing R&D activities, new product launches, joint ventures, partnerships, and mergers & acquisitions to sustain in the competitive global market.

Get Customization in the Report, Enquire Now @ https://www.futuremarketinsights.com/customization-available/rep-gb-3167

Key Segments of Enzyme Replacement Therapy Industry Survey

Enzyme Replacement Therapy Market by Therapeutic Condition:

  • Enzyme Replacement Therapy for Fabry Disease
  • Enzyme Replacement Therapy for Gaucher Disease
  • Enzyme Replacement Therapy for Mucopolysaccharidosis
  • Enzyme Replacement Therapy for Pompe Disease
  • Enzyme Replacement Therapy for Lysosomal Acid Lipase Deficiency
  • Others

Enzyme Replacement Therapy Market by Route of Administration:

  • Oral Enzyme Replacement Therapy
  • Injectable Enzyme Replacement Therapy

Enzyme Replacement Therapy Market by Distribution Channel:

  • Hospital Pharmacies
  • Specialty Treatment Pharmacies
  • Retail Pharmacies

Enzyme Replacement Therapy Market by Region:

  • North America Enzyme Replacement Therapy Market
  • Latin America Enzyme Replacement Therapy Market
  • Europe Enzyme Replacement Therapy Market
  • East Asia Enzyme Replacement Therapy Market
  • South Asia & Pacific Enzyme Replacement Therapy Market
  • Middle East & Africa (MEA) Enzyme Replacement Therapy Market

For more insights on the enzyme replacement therapy market, write in to Future Market Insights analysts at press@futuremarketinsights.com

Bone Screw System Market is likely to grow at a CAGR of 6.4% through 2028, Analysis By Future Market Insights

Future Market Insights tracks the performance of the global bone screw system market in a new publication titled “Bone Screw System Market: Global Industry Analysis 2013 – 2021 and Opportunity Assessment 2022 – 2028”. The bone screw system market is anticipated to record a year-over-year growth rate of 6.5% and reach a market value of US$ 1,963 Mn in 2028. Titanium will continue to account for the leading market revenue share by Material Type, accounting for 45.0% share of the global bone screw system market in 2022. In this report, the bone screw system market is segmented based on material type, patient anatomy, end user and region.

Get a Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-4050

Bone Screw System Market: Segmental Insights

Lower extremity segment leads the market for bone screw system owing to increasing number of cases registered due to prolonged effects of osteoporosis among the mass population. In contrast, there are limited number of companies conducting research activities for introducing novel products in the market. In terms of revenues, the lower extremity segment is expected to account for the largest revenue share of 39.2% in 2022 and is expected to witness significant growth during the forecast period. This growth in the lower extremity segment is expected to be primarily driven by rising awareness among the geriatric population and increasing number of orthopaedic cases undergoing surgical interventions.

Stainless steel is likely to be the preferred choice of material used in common practice due to its ready availability and cost efficiency as compared to titanium based screws and bioabsorbable material. Titanium holds a major share in the global market currently due to widespread usage. The bioabsorbable material segment has limited adoption in the market due to premium pricing over other bone screw products.

Among end users, hospitals are expected to hold the maximum share in the overall bone screw system market due to the large number of surgical procedures performed in hospitals using bone screws as compared to other end users such as ambulatory surgical centres and clinics. The hospitals end user segment is estimated to hold a market share of 65.6% in 2022.

Bone Screw System Market: Trends

Computer assisted technology is a revolutionary concept used in orthopaedic treatment procedures. Companies are focussing on collaboration with all end users to develop new effective products with better user interfaces. They are involving breakthrough options in this market to initiate a sense of revolution in using more advanced alternatives. In 2016, Surgebright in cooperation with the German Institute for Tissue and Cell Replacement (DIZG) in Berlin developed latest technology that uses real bone material to form a screw. 3D printing is another innovative technology that could be used in developing bone screws in the near future.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-4050

Bone Screw System Market: Regional Insights

The report tracks the global bone screw system market across the key geographies of North America, Europe, Latin America, Asia Pacific Excluding China, China and Middle East & Africa. This report assesses the trends driving each regional market and offers analysis and insights about the bone screw system market across specific countries in the assessed regions. North America accounts for a major share in the global bone screw system market and is expected to grow at a CAGR of 7.1% during the period of assessment. North America is projected to be the most lucrative market in the global bone screw system market with an attractiveness index of 2.3 during the forecast period due to the presence of leading manufacturers and implementation of healthcare reforms in the region.

Bone Screw System Market: Competition Tracking

The key players operating in the bone screw system market include companies such as Stryker Corporation, Zimmer Biomet Holdings Inc, CONMED Corporation, Arthrex, Orthofix, SMITH & NEPHEW, Johnson & Johnson (DePuy Synthes), Integra LifeSciences, Wright Medical Group N.V, SURGIVAL INTERNATIONAL, Spineology Inc, GPC Medical ltd., Osteogenics Biomedical,  Altimed, JEIL MEDICAL CORPORATION, Fine Science Tools, MEIRA Inc. and Medtronic.

Have Any Questions Regarding Bone Screw System Market Report, Ask Our Experts@ https://www.futuremarketinsights.com/ask-question/rep-gb-4050

Key Segments Covered in Bone Screw System Industry Survey

Bone Screw System by Material Type

  • Stainless-Steel Bone Screw System
  • Titanium Screw Bone Screw System
  • Bio-absorbable Screw Bone Screw System

Bone Screw System by Application

  • Lower Extremity Bone Screw System
  • Upper Extremity Bone Screw System
  • Spinal Bone Screw System
  • Other Bone Screw Systems

Bone Screw System by End User

  • Bone Screw System for Hospitals
  • Bone Screw System for Clinics
  • Bone Screw System for Ambulatory Surgical Centers

Bone Screw System by Region

  • North America Bone Screw System Market
  • Latin America Bone Screw System Market
  • Europe Bone Screw System Market
  • South Asia & Pacific Bone Screw System Market
  • East Asia Bone Screw System Market
  • MEA Bone Screw System Market

To study the growth strategies of the top manufacturers of bone screw systems and to understand the current market structure, write to Future Market Insights analysts at press@futuremarketinsights.com

Biologic Excipients Market is expected to be valued at US$ 1,706.2 million by the end of 2028

Future Market Insights (FMI) delivers key insights on the global biologic excipients market in its upcoming report titled “Biologic Excipients Market: Global Industry Analysis 2013–2017 and Opportunity Assessment 2018 – 2028”. In terms of revenue, the global biologic excipients market is projected to register a CAGR of 3.6% over the forecast period owing to various factors, regarding which FMI offers detailed insights and forecasts in this report.

Global Biologic Excipients Market: Segmental Analysis & Forecast

The global market is segmented based on excipient type, end user and region. Based on excipient type the market is segmented into polymers, sugar alcohols, polysorbates, inorganic salts, amino acids, surfactants and others. Polymers biologic excipients are anticipated to lead the biologic excipients market over the forecast period. Polymer biologic excipients account for the highest revenue share and are anticipated to witness a growth rate of 3.7% over the forecast period.

By end user, the market is segmented into biopharmaceutical manufacturers, contract research organisations/contract manufacturing organisations, and research organisations. Biopharmaceutical manufacturers is the leading segment in the global biologic excipients market over the forecast period. This segment accounts for a relatively higher revenue share, which is expected to register a CAGR of 6.0% over the forecast period.

Get a Free Sample Copy of the Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-6982

Global Biologic Excipients Market: Dynamics

Growth of the global biologic excipients market is primarily driven by rising global demand for medicines, greater uptake of biologics driving demand for parenteral formulations, increasing acquisition of contract research organisations, patent expiration of major blockbuster drugs, growing adoption of advanced drug delivery technologies, increasing research in pediatric formulations, growing demand for extended-release or sustained release formulations, increasing demand for oral solid drug formulations, rising demand from emerging economies pushing local drug production, and increasing per capita healthcare expenditure.

However, lack of proper data documentation on gras status of excipients, regulatory audits restricting supply capacity, regulatory hurdles detering novel excipient development, and stability testing of excipients imposing cost liabilities on drug manufacturers are some factors expected to hamper the growth of the global biologic excipients market over the forecast period.

A key trend witnessed in the biologic excipients market is increasing adoption of continuous processing of biologic excipients, dependence of large drug manufacturers on in-house biologic excipients production, vast proportion of imported excipients leading to production delays, and regulatory harmonisation with respect to gradation of excipients. Furthermore, the growing importance of developing biologic excipients by big players in order to enhance their product portfolio, growing importance for manufacturing authorisation, growing market for topical and parenteral applications and compulsory licensing promoting demand for biologic excipients are the key trends likely to be witnessed in the global biologic excipients market.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-6982

Global Biologic Excipients Market: Regional Analysis

The North America regional market is projected to dominate the global biologic excipients market, accounting for a maximum revenue share of the global market by 2017 end. The North America, Western Europe, and Asia Pacific markets accounted for 77.3% of the total biologic excipients market share in terms of value in 2017. Revenue from the market in APEJ is estimated to expand at a CAGR of 4.2% over the forecast period.

Some of the key players featured in this report on the global biologic excipients market include BASF Corporation, FMC Corporation, Wacker Chemie AG, Evonik Industries AG, Ashland Global Holdings Inc., Archer-Daniels-Midland Co., Roquette Freres S.A., The Dow Chemical Company, Colorcon Inc., Signet Chemical Co. Pvt. Ltd. This report discusses the individual strategies followed by these companies regarding bringing improvements in their products, creating new manufacturing facilities, market consolidation and advanced R&D initiatives. The report concludes with key takeaways for players already present in the market and new players planning to enter the market.

Ask Us Your Questions About This Report: https://www.futuremarketinsights.com/ask-question/rep-gb-6982

Market segmentation

The global biologic excipients market is segmented on the basis of excipient type into:

  • Polymers
  • Sugar Alcohols
  • Polysorbates
  • Inorganic Salts
  • Amino Acids
  • Surfactants
  • Others

For more insights on the biologic excipients market, write to the analysts of Future Market Insights at press@futuremarketinsights.com

Behavioural Health Market is projected to expand at 3.4% CAGR over the forecast period of 2022-2028

According to the latest market report published by Future Market Insights titled “Behavioural Health Market: Global Industry Analysis 2013–2021 and Opportunity Assessment 2022–2028”, the global behavioural health market is expected to expand at 3.4% CAGR over the forecast period 2022-2028.

North America is expected to hold the highest revenue share in the global behavioural health market over the forecast period. Currently, over 43.8 million adults in the U.S. are suffering from mental illness, which is fuelling demand for behavioral health services. Developing economies are witnessing large demand for home care services, day care services, and internet-counselling services, which is further expected to boost revenue growth of the behavioural health market in emerging markets.

Download FREE Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-5375

Global Behavioural Health Market: Segmental Analysis & Forecast

The global behavioural health market is segmented based on service type, disorder type, and region. Based on service type the market is segmented into outpatient counselling, intensive case management, home-based treatment services, inpatient hospital treatment, emergency mental health service and others. The inpatient hospital treatment services type segment is expected to represent highest revenue share in the global behavioural health market. Home-based treatment services are expected to gain popularity among people in the coming years and this segment is expected to expand at a CAGR of 4.0% over the forecast period.

Based on disorder type the market is segmented into the anxiety disorder, bipolar disorder, depression, eating disorder, post-traumatic stress disorder (PSTD), substance abuse disorder and others. Among all disorder types, the anxiety disorder segment is anticipated to continue to lead the global behavioural health market due to a high patient pool globally and high adoption of behavioural health therapy among patients suffering from anxiety issues. According to the WHO, globally 260 million people are suffering from anxiety disorder.

Increased exposure to drugs and alcohol among young adults and strengthening insurance coverage policies for mental health are identified as key trends among end users in the global behavioural health market. Furthermore, rehabilitation programs for substance abuse disorder patients, outpatient counselling for ADHD affected children, and campaigns to spread awareness regarding mental disorders and drug addiction, etc. are some of the major factors that are driving the growth of the global behavioural health market. Government initiatives to reduce the burden of mental illness and rehabilitation services by non-government organizations (NGO) are further expected to positively impact revenue growth of the global behavioural health market.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-5375

Global Behavioural Health Market: Competition Analysis

The global market for behavioural health is fragmented with many local and regional level players operating in the worldwide market. Some of the key players featured in the global behavioural health market report include Acadia Healthcare Co., Inc., Universal Health Services Inc., Magellan Health Inc., National Mentor Holdings Inc., Behavioral Health Services Inc., Behavioral Health Network Inc., North Range Behavioral Health, Strategic Behavioral Health LLC, Seton Healthcare Family (Ascension Health) and Ocean Mental Health Services Inc. etc. among others.

Feel free to ask your queries at https://www.futuremarketinsights.com/ask-question/rep-gb-5375

Key Segments Covered in Behavioural Health Industry Survey

Behavioural Health by Service Type

  • Outpatient Counselling for Behavioural Health
  • Intensive Case Management for Behavioural Health
  • Home-based Treatment Services for Behavioural Health
  • Inpatient Hospital Treatment for Behavioural Health
  • Emergency Mental Health Service for Behavioural Health
  • Others

Behavioural Health by Disorder Type

  • Anxiety Disorder
  • ADHD
  • Bipolar Disorders
  • Depression
  • Eating Disorder
  • Post-traumatic Stress Disorder (PTSD)
  • Substance Abuse Disorder
  • Others

Behavioural Health Market by Region

  • North America Behavioural Health Market
  • Latin America Behavioural Health Market
  • Europe Behavioural Health Market
  • East Asia Behavioural Health Market
  • South Asia & Pacific Behavioural Health Market
  • Middle East & Africa (MEA) Behavioural Health Market

For more insights on the global market for behavioural health, write in to Future Market Insights analysts at press@futuremarketinsights.com

Stroke Assistive Devices Market Current Scenario Trends, Comprehensive Analysis and Regional Forecast to 2028

An assistive device, commonly, is a medical equipment that assists a disabled person or patients having inability to perform their daily tasks due to acute stroke or traumatic disorders. When a person encounters acute stroke, it becomes difficult for that patient to recover immediately from after effects of acute stroke that represents reduced mobility in limbs and extreme difficulties in performing their daily tasks such as dressing, bathing, grooming, cooking, feeding, etc. Thus, after having a stroke or trauma, most of the patients require assistive devices in order to maximize their independent functioning. In general, assistive devices find major applications for the disease indications including stroke, orthopedic, cognitive and motor skills, sports and others.

One of the most commonly used assistive device prescribed for stroke survivors is Mobility Assistive Devices (MAD). These mobility assistive devices for stroke patients offer improved mobility and allows them to independently perform the mobility-related tasks. A person who encountered stroke often has to undergo a long rehabilitation. Financed by the EU Research and Innovation programme Horizon H2020, robot-based technologies have been under substantial use to speed up the rehabilitation of stroke patients under its project called “the RETRAINER”. The technology used under this project allows the stroke patients to utilize their own arms and hands, as much and as soon, after the trauma or post-stroke in order to achieve best results in the rehabilitation.

After encountering stroke, a person usually goes to the physiotherapist for treatment or post-stroke recovery. The treatment may go wrong if the physiotherapist is not trained well, however, a patient receives quality treatment if these orthopedic treatment procedures are performed using robotic assistive devices. Stroke assistive devices are highly utilized in rehabilitation process to treat a physically disabled person in order to improve their daily performance. Thus, with the emergence of high incidence for stroke and trauma cases, stroke assistive devices experience greater demand from the end customers. Thus generating large revenues in the stroke assistive devices market.

Stroke assistive devices market on the basis of device type is classified into two main types – robotic exoskeletons, stroke-rehabilitation gloves, and others. Stroke rehabilitation is a treatment process solely targeted towards restoration of intellectual, physical, mental and social capabilities of a patient affected by stroke.

The growing incidence of stroke in U.S. population tends to be the leading reason to propel the growth of stroke assistive devices market across the globe. The growing adoption of stroke assistive devices by the physicians to treat post stroke effects is further anticipated to drive the demand for stroke assistive devices and thereby increasing revenue generation in stroke assistive devices market.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-6921

Stroke Assistive Devices: Market Dynamics

Growing innovation and funding in neuromuscular & stroke rehabilitation, availability of high-tech and effective stroke assistive devices such as wearable wirelessly controlled rehabilitation device in the market, and growing population of stroke patients owing to increasing incidence of neuromuscular disorders and stroke across the globe is expected to be the key factor driving growth of stroke assistive devices market.

Rapid increase in physical disabilities caused due to increasing prevalence of disorders including spinal cord injury, rheumatoid arthritis, cerebral palsy and additional ageing disabilities is further expected to surge the demand for robotic rehabilitation and stroke-assistive technologies. Thus, the demand for stroke assistive devices has registered an upsurge, thereby generating more revenues in stroke assistive devices market. Also, growing mergers and acquisitions among the leading players in order to increase their geographical footprint is another factor propelling the growth of stroke assistive devices market.

However, lack of awareness among the people about new robotic technologies to assist stroke affected patient, particularly in the emerging economies, coupled with high cost of assistive technologies and robotic rehabilitation are some of the factors restraining the stroke assistive devices market growth.

Request Report Methodology: https://www.futuremarketinsights.com/askus/rep-gb-6921

Stroke Assistive Devices Market: Overview

Based on device type, robotic devices including robotic exoskeletons and stroke-rehabilitation gloves register the highest demand in the stroke assistive devices market owing to the better mobility results registered with usage of this device as compared to others. Stroke assistive devices found major usage in management of acute stroke and chronic neuromuscular disorders such as Multiple Sclerosis, Guillain Barre Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Cerebral Palsy, and Muscular Dystrophy.

Rising number of disabled people due to the above mentioned disorders is one of the major factor driving the demand for stroke assistive devices for early management of patients effected with stroke, thereby fueling the stroke assistive devices market across the globe. However, the growing footprint of stroke assistive devices manufacturers for chronic disorders management applications coupled with rising demand for these devices is further expected to drive the revenue generation in global stroke assistive devices market.

Stroke Assistive Devices Market: Region-wise Outlook

On the basis of geography, global stroke assistive devices market is segmented into seven key regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and Middle East & Africa. Europe is projected to hold largest shares in the global stroke assistive devices market primarily due to increasing prevalence of disabilities in the region owing to growing incidence of stroke and neuromuscular disorders, enhanced healthcare infrastructure and increased R&D expenditure for manufacturing stroke-assistive devices. In Russia, about 13 million people are registered to live with certain post-stroke disabilities, constituting around 9% of the total Russian population. North America followed by Western Europe is expected to be the second dominating region in global stroke assistive devices market worldwide.

Stroke Assistive Devices Market: Key Players

Some of the key players present in global stroke assistive devices market are AnthroTronix, Inc., ReWalk Robotics, Mazor Robotics Ltd., Intuitive Surgical Inc., Interactive Motion Technologies, Bioxtreme Robotics Rehabilitation, Accuray, Inc., Health Robotics S.R.L., Ekso Bionics Holdings, Inc., and others.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

Get Customization in the Report, Enquire Now @ https://www.futuremarketinsights.com/customization-available/rep-gb-6921

Stroke Assistive Devices Market: Segmentation

The global stroke assistive devices market is segmented by device type and end user:

Segmentation by Device Type

  • Mobility Devices
  • Wheelchairs
  • Mobility Scooters
  • Walkers and Rollators
  • Cranes and Crutches
  • Transfer Lifts
  • Others
  • Robotic Aids
  • Robotic Exoskeletons
  • Stroke-Rehabilitation Gloves
  • Robotic Gait Trainers
  • Medical and Bathroom Assistive Devices
  • Shower Chairs and Tub Benches
  • Toilet Seats and Bedside Commodes
  • Other Bathing/Dressing Aids
  • Ostomy Products
  • Medical Beds
  • Reading and Vision Aids
  • Hearing Devices

Segmentation by End User

  • Hospitals
  • Specialty Clinics
  • Physiotherapy Centers
  • Ambulatory Surgical Centers
  • Home Care Settings
  • Others

Global Boron Trifluoride & Complexes Market Is Projected To Grow At A CAGR Of ~ 5% During The Forecast Period Of 2019-2029

The global boron trifluoride & complexes market sales are anticipated to be valued at ~US$ 233 Mn by the end of 2019, witnessing a strong Y-O-Y growth of ~4.5% over the year 2018, finds a recent study published by Future Market Insights. Asia Pacific excluding Japan is projected to hold more than half of the market value share by end of 2019 and grow with a significant CAGR in the near future, opines the study.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-4067

Boron trifluoride is amongst the strongest Lewis acids (electron pair acceptor), and therefore, it finds application as a catalyst for a number of organic synthesis reactions including polymerization, alkylation, isomerization, and other chemical synthesis reactions.

A number of polymer derivatives are being made in the presence of boron trifluoride as a catalyst such as polypropylene and polyethylene. Boron trifluoride gas and its complexes are also being used for manufacturing rubber and other elastomeric polymers, which are increasingly being used across a number of end-use industries. Moreover, boron trifluoride is also used for the synthesis of different range of hydrocarbons such as aromatic hydrocarbons, unsaturated hydrocarbons, alcohols, phenols, and many others.

With growth in oil and gas and petrochemical industries in the region, through shale gas extraction, there has been tremendous growth in hydrocarbons synthesis and other chemicals, which use BF3 as a major catalyst during reaction. This, in turn, is driving the demand for boron trifluoride & complexes in the market, opines the FMI study.

The study also finds that the demand for boron trifluoride (BF3) gas and di ethyl etherate are anticipated to grow with significant CAGRs in terms of value during the forecast period. Furthermore, the applications of boron trifluoride & complexes as catalysts are projected to grow with a healthy CAGR owing to the huge demand generated from synthetic reactions such as polymerization, alkylation, isomerization, and other chemical synthesis.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-4067

Stringent Regulations on Manufacturing of Boron Trifluoride & Complexes Could Hinder Growth

Boron trifluoride, especially in the gaseous form, is considered to be a hazardous, toxic, and very corrosive substance. Therefore, there are a number of regulations pertaining to its manufacturing, transportation, labelling, exposure limit, labelling, and others.

Packaging and transportation of the gas is done under extremely high pressure and is a major challenge for manufacturers, distributors, and end users as well. Moreover, for using boron trifluoride in the gaseous form, there must be an appropriate unloading facility at the consumers’ end, which is leading to many of the end users using boron trifluoride in the complexes form. This factor is estimated to hinder the global boron trifluoride market by the end of the forecast period.

For any queries linked with the report, ask an analyst
https://www.futuremarketinsights.com/ask-question/rep-gb-4067

Boron Trifluoride & Complexes Market: Vendor Insights

The boron trifluoride & complexes market is fairly fragmented due to the presence of manufacturers at the regional level. Few of them included in the global boron trifluoride & complexes market report are – BASF SE, Air Liquide, Praxair Technology, Inc., Honeywell International Inc., Matheson Tri-Gas Inc., Gulbrandsen, Entegris, Inc., The Linde Group, Stella Chemifa Corporation, Hunan Heaven Materials Development Co., Arkema, ZIbo Shuanglian Petroleum & Chemical Co., Ltd., NAVIN FLUORINE INTERNATIONAL LIMITED, Qingzhou Chenkai Chemical Co., Ltd., ZIbo Shuanglian Petroleum & Chemical Co., Ltd., and Tanfac Industries Ltd.

Companies are focusing on mergers and acquisitions of big and small players in the market for expansion of sales and to gain competitive leverage over other players. For instance, in October 2016, the Honeywell International Inc. acquired the Research Chemicals Business from Sigma-Aldrich. The acquisition enabled the company to offer a broad line of inorganic chemicals and solvents for demanding applications.

Plant-Based Milk To Increase At 8.8% CAGR Between 2021 And 2031

Popularity of vegan diets can be attributed to popularity of veganism and rising focus on sustainable living. As per Future Market Insights (FMI), these factors will create conducive environment for the expansion of the plant based milk market. The report also forecasts the sales of plant-based milk to increase at 8.8% CAGR between 2021 and 2031.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-13818

Concerns about the humane treatment of animals have also had a significant influence in the gradual shift toward vegan diets. The market for plant-based milk is predicted to expand as a result of these factors.

Consumers have become more appreciative of and inclined toward plant-based products, such as juices and other plant-based beverages, as health and wellness concerns have grown, due to the rise in prevalence of obesity, diabetes, and cardiovascular diseases.

Plant-based goods contribute to healthy eating habits by providing higher nutritional content, vitamins, minerals, and healthy fats. Veganism is gradually becoming more popular. Some of the countries have been identified to represent the trend from the fore at global forums. For instance:

  • In 2016, Singapore earned the spot of second-most vegan friendly Asian city by PETA Asia. Singapore was also titled the top 6th vegan city in the world by Happy Cow.
  • Hong Kong was listed in the top 10 vegan friendly countries by Peta Asia in 2020. According to a vegan business platform, Eco Warrior Princess, roughly 25% -70% of Hong Kong residents consume vegan meals.
  • Thailand witnessed the launch of several vegan restaurants and food outlets recently such as Veganerie, Vistro, May Veggie Home, and Swees among others.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-13818

Key Takeaways from the Plant-based Milk Market Study:

  • The U.S. is estimated to account for more than 80% of the North America market in 2021, supported by consumer awareness regarding nutritional foods.
  • According to FMI’s analysis, China is estimated to account for more than 60% of the Asia Pacific market in 2021, supported by easy availability of raw materials.
  • The U.K. is a high potential market in Europe, accounting for over 9.4% value share, supported by the popularity of clean label trends.
  • Sales via online retail are expected to grow at 10.8% CAGR through 2031.

“Consumers across the globe are becoming increasingly health-conscious. Increasing focus on health and wellness have been drawing them towards plant-based milk in comparison to regular diary. This also is encouraging the market players to put greater emphasis on product launches,” said a lead analyst at FMI. 

For any queries linked with the report, ask an analyst
https://www.futuremarketinsights.com/ask-question/rep-gb-13818

Sustainability of Plant-based Milk Production to Increase its Appeal

Plant-based milk is popular among customers because of benefits it provides in terms of sustainability, nutrition, and convenience. Consumers now demand food & beverages that are good for both their bodies and environment.

There are various concerns with conventional dairy products, including inhumane livestock rearing & addition of pesticides and chemicals to dairy milk, among others. Because of its vegan origins and branding as a health product, demand for plant based milk such as oat milk is likely to increase.

Who is winning?

Manufacturers of plant-based milk are trying to attract customers by packaging their products in cartons which are creatively and beautifully crafted. It helps plant-based milk producers differentiate their beverage from the rest and draws more customers as buyers choose to purchase a more visually appealing product compared to a typical product.

Some of the leading companies offering plant-based milk are Groupe Danone, Alpina Foods, Blue Diamond Growers, Inc., Döhler GmbH, Earth’s Own Food Company Inc, Elden Foods Inc, Freedom Foods Group Ltd, Goya Foods, Groupe Danone, Hain Celestial Group, Inc, Kaslink Foods Oy Ltd, Living Harvest Foods Inc, Liwayway Holdings Company Limited, Mc Cormick & Co., Natura Foods, Nutriops SL, Organic Valley, Pacific Foods of Oregon, Inc, and others.